Nucleoside Reverse Transcriptase Inhibitor (NRTIs)
Molecular Weight: 229.2589
FDA label informationFDA label information
Several FDA-approved drug labels may be available for lamivudine. Clinical Info provides the following link to the DailyMed drug label solely as an example of the labels available for lamivudine. Inclusion or absence of a drug label link on the Clinical Info site does not imply endorsement or lack thereof by Clinical Info. Search DailyMed or Drugs@FDA to access more information on lamivudine, including additional drug labels and any generic equivalents.